日本の糖尿病デバイス市場レポート：タイプ別、流通チャネル別、地域別、2025年～2033年

日本の糖尿病デバイスの市場規模は2024年に19億3,600万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに24億8,700万米ドルに達し、2025～2033年の成長率（CAGR）は2.8％になると予測しています。糖尿病管理、モニタリング、治療という多面的な需要への対応に焦点を当てた、大幅な技術革新と技術進歩が、主に市場成長の原動力となっています。

本レポートで扱う主な質問

• 日本の糖尿病デバイス市場はこれまでどのように推移し、今後どのように推移していくのか？
• COVID-19が日本の糖尿病デバイス市場に与えた影響は？
• 日本の糖尿病デバイス市場のタイプ別区分は？
• 日本の糖尿病デバイス市場の流通チャネル別区分は？
• 日本の糖尿病デバイス市場のバリューチェーンにおける様々なステージとは？
• 日本の糖尿病デバイスの主な促進要因と課題は？
• 日本の糖尿病デバイス市場の構造と主要プレーヤーは？
• 日本の糖尿病デバイス市場における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
• 市場推定
• 調査手法

第3章 エグゼクティブサマリー

第4章 日本の糖尿病デバイス市場：イントロダクション

• 概要
• 市場力学
• 業界動向
• 競合情報

第5章 日本の糖尿病デバイス市場情勢

• 過去および現在の市場動向（2019～2024年）
• 市場予測（2025～2033年）

第6章 日本の糖尿病デバイス市場：タイプ別内訳

• 管理デバイス
• 監視デバイス

第7章 日本の糖尿病デバイス市場：流通チャネル別内訳

• 病院薬局
• 小売薬局
• 糖尿病クリニック/センター
• オンライン薬局
• その他

第8章 日本の糖尿病デバイス市場：競合情勢

• 概要
• 市場構造
• 市場企業のポジショニング
• 主要成功戦略
• 競合ダッシュボード
• 企業評価象限

第9章 主要企業のプロファイル

第10章 日本の糖尿病デバイス市場：業界分析

• 促進要因、抑制要因、機会
• ポーターのファイブフォース分析
• バリューチェーン分析

第11章 付録

Japan diabetes devices market size reached USD 1,936 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 2,487 Million by 2033, exhibiting a growth rate (CAGR) of 2.8% during 2025-2033. Significant innovations and technological advancements, focused on addressing the multifaceted demands of diabetic management, monitoring, and treatment are primarily driving the market growth.

Diabetes devices refer to a category of medical equipment specifically designed to manage, monitor, and treat diabetes, a chronic condition characterized by elevated blood sugar levels. These devices play an essential role in assisting individuals with diabetes to maintain optimal blood glucose levels and prevent complications associated with uncontrolled diabetes. Diabetes devices include blood glucose monitors, insulin pumps, insulin pens, and continuous glucose monitoring (CGM) systems, amongst others. Blood glucose monitors are utilized for intermittent blood sugar testing, while the latter provide real-time glucose readings throughout the day. Insulin pumps and pens are crucial for the delivery of insulin, a hormone essential for the metabolism of carbohydrates, fats, and proteins. These devices, with their advancements in technology, are becoming more user-friendly, accurate, and minimally invasive, catering to the specific needs and preferences of diabetic patients. The incorporation of digital technologies such as apps and telemedicine platforms also helps in better diabetes management by offering personalized care and remote monitoring capabilities. In essence, diabetes devices are pivotal in empowering individuals with diabetes to lead a healthier and more manageable life, fostering advancements in medical technology and healthcare.

Japan Diabetes Devices Market Trends:

The Japan diabetes devices market is witnessing a period of substantial growth, driven by a confluence of trends and drivers, including an aging population and increasing prevalence of diabetes within the country. With Japan being home to a considerable elderly demographic, the necessity for innovative and efficient diabetes management devices is more paramount than ever, propelling advancements and investments in this sector. The surge in health consciousness and self-management of diabetes is leading to increased demand for user-friendly, accurate, and technologically advanced devices, such as continuous glucose monitoring systems and insulin delivery devices. Technological innovations and the integration of IoT and AI are significant trends in the market, enhancing the functionalities of diabetes devices, offering real-time monitoring, data analysis, and personalized recommendations, thus elevating the standard of diabetes care. The government's supportive policies and initiatives aimed at healthcare innovation and chronic disease management also act as catalysts, bolstering the market's trajectory. Moreover, the rise in partnerships between tech companies and medical device manufacturers is fostering the development of more sophisticated solutions. The growing acceptance and adoption of these advanced diabetes devices among healthcare providers and patients are anticipated to further augment the market growth. The emphasis on minimally invasive or non-invasive devices and the proliferation of telehealth and remote monitoring are reshaping the landscape of diabetes management in Japan, indicating a promising future for the diabetes devices market in the region.

Japan Diabetes Devices Market Segmentation:

Type Insights:

• Management Devices
• oInsulin Pump
• oInsulin Syringes
• oCartridges in Reusable Pens
• oInsulin Disposable Pens
• oJet Injectors
• Monitoring Devices
• Self-monitoring Blood Glucose
• oContinuous Glucose Monitoring

Distribution Channel Insights:

• Hospital Pharmacies
• Retail Pharmacies
• Diabetes Clinics/Centers
• Online Pharmacies
• Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the key players include:

• ARKRAY Inc.
• Ascensia Diabetes Care Holdings AG
• Dexcom Inc.
• Terumo Corporation

Key Questions Answered in This Report:

• How has the Japan diabetes devices market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the Japan diabetes devices market?
• What is the breakup of the Japan diabetes devices market on the basis of type?
• What is the breakup of the Japan diabetes devices market on the basis of distribution channel?
• What are the various stages in the value chain of the Japan diabetes devices market?
• What are the key driving factors and challenges in the Japan diabetes devices?
• What is the structure of the Japan diabetes devices market and who are the key players?
• What is the degree of competition in the Japan diabetes devices market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Diabetes Devices Market - Introduction

• 4.1 Overview
• 4.2 Market Dynamics
• 4.3 Industry Trends
• 4.4 Competitive Intelligence

5 Japan Diabetes Devices Market Landscape

• 5.1 Historical and Current Market Trends (2019-2024)
• 5.2 Market Forecast (2025-2033)

6 Japan Diabetes Devices Market - Breakup by Type

• 6.1 Management Devices
  • 6.1.1 Overview
  • 6.1.2 Historical and Current Market Trends (2019-2024)
  • 6.1.3 Market Segmentation
    • 6.1.3.1 Insulin Pump
    • 6.1.3.2 Insulin Syringes
    • 6.1.3.3 Cartridges in Reusable Pens
    • 6.1.3.4 Insulin Disposable Pens
    • 6.1.3.5 Jet Injectors
  • 6.1.4 Market Forecast (2025-2033)
• 6.2 Monitoring Devices
  • 6.2.1 Overview
  • 6.2.2 Historical and Current Market Trends (2019-2024)
  • 6.2.3 Market Segmentation
    • 6.2.3.1 Self-monitoring Blood Glucose
    • 6.2.3.2 Continuous Glucose Monitoring
  • 6.2.4 Market Forecast (2025-2033)

7 Japan Diabetes Devices Market - Breakup by Distribution Channel

• 7.1 Hospital Pharmacies
  • 7.1.1 Overview
  • 7.1.2 Historical and Current Market Trends (2019-2024)
  • 7.1.3 Market Forecast (2025-2033)
• 7.2 Retail Pharmacies
  • 7.2.1 Overview
  • 7.2.2 Historical and Current Market Trends (2019-2024)
  • 7.2.3 Market Forecast (2025-2033)
• 7.3 Diabetes Clinics/Centers
  • 7.3.1 Overview
  • 7.3.2 Historical and Current Market Trends (2019-2024)
  • 7.3.3 Market Forecast (2025-2033)
• 7.4 Online Pharmacies
  • 7.4.1 Overview
  • 7.4.2 Historical and Current Market Trends (2019-2024)
  • 7.4.3 Market Forecast (2025-2033)
• 7.5 Others
  • 7.5.1 Historical and Current Market Trends (2019-2024)
  • 7.5.2 Market Forecast (2025-2033)

8 Japan Diabetes Devices Market - Competitive Landscape

• 8.1 Overview
• 8.2 Market Structure
• 8.3 Market Player Positioning
• 8.4 Top Winning Strategies
• 8.5 Competitive Dashboard
• 8.6 Company Evaluation Quadrant

9 Profiles of Key Players

• 9.1 ARKRAY Inc.
  • 9.1.1 Business Overview
  • 9.1.2 Product Portfolio
  • 9.1.3 Business Strategies
  • 9.1.4 SWOT Analysis
  • 9.1.5 Major News and Events
• 9.2 Ascensia Diabetes Care Holdings AG
  • 9.2.1 Business Overview
  • 9.2.2 Product Portfolio
  • 9.2.3 Business Strategies
  • 9.2.4 SWOT Analysis
  • 9.2.5 Major News and Events
• 9.3 Dexcom Inc.
  • 9.3.1 Business Overview
  • 9.3.2 Product Portfolio
  • 9.3.3 Business Strategies
  • 9.3.4 SWOT Analysis
  • 9.3.5 Major News and Events
• 9.4 Terumo Corporation
  • 9.4.1 Business Overview
  • 9.4.2 Product Portfolio
  • 9.4.3 Business Strategies
  • 9.4.4 SWOT Analysis
  • 9.4.5 Major News and Events

10 Japan Diabetes Devices Market - Industry Analysis

• 10.1 Drivers, Restraints and Opportunities
  • 10.1.1 Overview
  • 10.1.2 Drivers
  • 10.1.3 Restraints
  • 10.1.4 Opportunities
• 10.2 Porters Five Forces Analysis
  • 10.2.1 Overview
  • 10.2.2 Bargaining Power of Buyers
  • 10.2.3 Bargaining Power of Suppliers
  • 10.2.4 Degree of Competition
  • 10.2.5 Threat of New Entrants
  • 10.2.6 Threat of Substitutes
• 10.3 Value Chain Analysis

11 Appendix